Title:
DRUG EFFECTIVE FOR LYMPHOGENOUS DRUG ADMINISTRATING METHOD
Document Type and Number:
WIPO Patent Application WO/2018/066278
Kind Code:
A1
Abstract:
Provided is a pharmaceutical composition suitable for lymphogenous drug administration in which an anticancer drug is administered into a lymph node. The pharmaceutical composition which is for cancer therapy or prophylactic therapy and which is administered into a lymph node, contains, as an active ingredient, at least one anticancer drug selected from antimetabolites and plant alkaloid-based anticancer drugs.
Inventors:
KODAMA TETSUYA (JP)
MORI SHIRO (JP)
NOHARA GO (JP)
MORI SHIRO (JP)
NOHARA GO (JP)
Application Number:
PCT/JP2017/031483
Publication Date:
April 12, 2018
Filing Date:
August 31, 2017
Export Citation:
Assignee:
UNIV TOHOKU (JP)
YAKULT HONSHA KK (JP)
YAKULT HONSHA KK (JP)
International Classes:
A61K45/00; A61K31/4745; A61K31/513; A61P35/00
Foreign References:
| JP2011518217A | 2011-06-23 |
Other References:
CARR J. ET AL.: "Lymphatic metastasis; lymphangiochemotherapy of mammary cancer: ascitic form of rat mammary adenocarcinoma 13762", CLINICAL AND EXPERIMENTAL METASTASIS, vol. 1, no. 1, 1983, pages 29 - 38, XP009514657, DOI: 10.1007/BF00118470
"Hikari Glucose Injection 5%, 10%, 20%, 30%, 50%", IYAKUHIN INTERVIEW FORM, vol. 5, 2015, pages 1 - 26, XP009518630
SHIGEKI KATO; SHIRO MORI; TETSUYA KODAMA, JOURNAL OF CANCER, vol. 6, no. 12, 2015, pages 1282 - 1294
J IMMUNOL METHODS, vol. 389, no. 1-2, 2013, pages 69 - 78
PLOS ONE, vol. 8, no. 2, 2013, pages e55797
J IMMUNOL METHODS, vol. 389, no. 1-2, 29 March 2013 (2013-03-29), pages 69 - 78
See also references of EP 3524269A4
"Hikari Glucose Injection 5%, 10%, 20%, 30%, 50%", IYAKUHIN INTERVIEW FORM, vol. 5, 2015, pages 1 - 26, XP009518630
SHIGEKI KATO; SHIRO MORI; TETSUYA KODAMA, JOURNAL OF CANCER, vol. 6, no. 12, 2015, pages 1282 - 1294
J IMMUNOL METHODS, vol. 389, no. 1-2, 2013, pages 69 - 78
PLOS ONE, vol. 8, no. 2, 2013, pages e55797
J IMMUNOL METHODS, vol. 389, no. 1-2, 29 March 2013 (2013-03-29), pages 69 - 78
See also references of EP 3524269A4
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Download PDF: